Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
329 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (22)
  • (-) Currently Recruiting (5)
  • Closed (17)

Medical Condition

  • Show all (329)
  • Addiction (4)
  • Allergy, Asthma, & Immunology (1)
  • Autoimmune Disorders (2)
  • Blood Disorders (2)
  • Bone & Muscle (2)
  • Cancer (88)
    • (-) Bladder Cancer (2)
    • Brain Cancer (9)
    • Breast Cancer (10)
    • Gastrointestinal (2)
    • Gynecologic Cancer (6)
    • Kidney Cancer (1)
    • Leukemia (7)
    • Liver Cancer (2)
    • Lung Cancer (4)
    • Lymphoma (9)
    • Multiple Myeloma (4)
    • Pancreatic Cancer (6)
    • Prostate Cancer (4)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (6)
  • Ear, Nose and Throat (6)
  • Endocrine & Metabolic Disease (1)
  • Gastrointestinal and Digestive Diseases (5)
  • Hair and Skin Disorders (2)
  • Healthy Volunteers (45)
  • Heart Disease (21)
  • Infectious Disease (12)
  • Liver Disease (13)
  • Lung Disease (2)
  • Neurological Disorders (42)
    • Alzheimer's Disease (8)
    • Brain Tumors (12)
    • Cerebral Palsy (2)
    • (-) Dementia (3)
    • Huntington's Disease (1)
    • Multiple Sclerosis (3)
    • Neuromuscular (2)
    • Neuropathy (1)
    • Parkinson's Disease (2)
  • Nutrition (1)
  • Obesity (7)
  • Obstetrics & Gynecology (12)
  • Pediatrics (21)
  • Psychiatric Disorders (7)
  • Rehabilitation (1)
  • Stroke (1)
  • Transplant (16)
  • Vascular Conditions (1)
Displaying 1 - 5 of 5

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (LOXO-LNC-24001)

Condition: Cancer / Bladder Cancer
Investigator: Alexander Wei, MD
Status: Currently Recruiting
The purpose of this study is to determine whether using LY4052031 in a type of cancer that may have tumor cells that express a protein called Nectin-4 is safe and how well the cancer responds to the study drug. LY4052031 has not been approved by the US Food and Drug Administration (FDA). This is a first in human study and all of the risks are not fully…
Read More

Early Age-Related Hearing Loss Investigation (EARHLI)

Condition: Neurological Disorders / Dementia
Investigator: Justin Golub, MD, MS
Status: Currently Recruiting
Early Age-Related Hearing Loss Investigation (EARHLI) is a study to obtain information on how a hearing aid-based intervention can prevent cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). Age-related hearing loss (ARHL) is the third most common chronic condition in older adults. The…
Read More

NeoSTOP-IT: Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer

Condition: Cancer / Bladder Cancer
Investigator: Alexander Wei, MD
Status: Currently Recruiting
The purpose of this study is for patients with a localized bladder cancer called muscle-invasive bladder cancer. Muscle-invasive bladder cancer is usually treated with a combination of chemotherapy and surgery. This surgery removes the entire bladder, which changes how they urinate for the rest of their life. Some patients will have a small opening in the…
Read More

Resource for Early Onset Alzheimer's Disease Research (READR)

Condition: Neurological Disorders / Dementia
Investigator: Christiane Reitz, MD, PhD
Status: Currently Recruiting
We are recruiting individuals and/or families with members under the age of 65 who have dementia or are experiencing memory problems. Our initial screening can be completed in person or over the phone. The evaluation will take about 1 to 1.5 hours per person and includes a: 1. Blood sample (5 tablespoons) or saliva (1 teaspoon) collection: These blood…
Read More

Alzheimer's Disease Research Center (ADRC)

Condition: Neurological Disorders / Dementia
Investigator: Scott Small, MD
Status: Currently Recruiting
For over 30 years, The Columbia University Alzheimer's Disease Research Center (ADRC) has worked with thousands of participants who have helped provide important insights into how the brain ages and why Alzheimer's disease may develop. We are actively recruiting adults 65 years of age and older who share our commitment to be part of this…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science